| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2174/138945008784221170 |
| P698 | PubMed publication ID | 18473770 |
| P50 | author | Silvio Danese | Q89573798 |
| P2093 | author name string | Alessandro Repici | |
| Alberto Malesci | |||
| Stefania Vetrano | |||
| Tommaso Stefanelli | |||
| P433 | issue | 5 | |
| P921 | main subject | inflammatory bowel diseases | Q917447 |
| pathophysiology | Q1135939 | ||
| drug discovery | Q1418791 | ||
| P304 | page(s) | 413-418 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | Current Drug Targets | Q15724627 |
| P1476 | title | New Insights into Inflammatory Bowel Disease Pathophysiology: Paving the Way for Novel Therapeutic Targets | |
| P478 | volume | 9 |
| Q39817181 | A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments. |
| Q90278080 | Comprehensive analysis of gene expression profiles provides insight into the pathogenesis of Crohn's disease |
| Q33420096 | Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study |
| Q36425014 | Lacrimal Gland Inflammation Deregulates Extracellular Matrix Remodeling and Alters Molecular Signature of Epithelial Stem/Progenitor Cells |
| Q58774497 | Mechanisms regulating intestinal barrier integrity and its pathological implications |
| Q39431263 | Pathogenic Yersinia DNA in intestinal specimens of pediatric patients with Crohn's disease |
| Q37991447 | Prevention of postoperative recurrence of Crohn's disease |
| Q92239061 | RWHMDA: Random Walk on Hypergraph for Microbe-Disease Association Prediction |
| Q91895123 | Smoking and microbiome in oral, airway, gut and some systemic diseases |
| Q33809040 | Systems Pharmacological Approach of Pulsatillae Radix on Treating Crohn's Disease |
| Q47123805 | TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases? |
| Q50757657 | Thiopurines are associated with a reduction in surgical re-resections in patients with Crohn's disease: a long-term follow-up study in a regional and academic cohort. |
| Q38804021 | VEN-120, a recombinant human lactoferrin, promotes a regulatory T cell (Treg) phenotype and drives resolution of inflammation in distinct murine models of inflammatory bowel disease |
Search more.